$19.03
0.613.31%
At close: -
$18.50
-0.53-2.79%
After Hours: Jan 28, 8:38 AM EDT
Comments
Loading...
Cadrenal Therapeutics (NASDAQ:CVKD) Stock, Earnings Estimates, EPS, And Revenue
Cadrenal Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 10
EPS Estimate
$-1.870
Quarterly Revenue Estimate
–
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Cadrenal Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Cadrenal Therapeutics (CVKD) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-07 | $-2.18 | $-1.93 | -13.0 % |
| Q2 | 2024-08-07 | $-2.25 | $-1.20 | -87.5 % |
| Q1 | 2024-05-09 | $-1.50 | $-1.05 | -42.9 % |
| Q4 | 2024-03-11 | $-0.75 | $-1.20 | 37.5 % |
Cadrenal Therapeutics (CVKD) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Cadrenal Therapeutics (NASDAQ:CVKD) reporting earnings?
Cadrenal Therapeutics (CVKD) is scheduled to report earnings on March 10, 2025. The last reported earnings were for reported on November 7, 2024 for Q3.
What were the latest earnings per share (EPS) for Cadrenal Therapeutics (NASDAQ:CVKD)?
The Actual EPS was $-2.18, which missed the estimate of $-1.93.
What were Cadrenal Therapeutics’s (NASDAQ:CVKD) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.